California Voters Face $8.4 Billion Choice on Medical Research Measure
Sacramento, Thursday, 24 September 2026.
Proposition 38 proposes borrowing $8.4 billion for immunology research to counter federal funding cuts, sparking debate between healthcare advocates and progressive groups over funding allocation and costs.
Proposition 38 Funding Structure and Allocation
On September 23, 2026, a coalition comprising over 60 patient advocacy, medical, and research organizations launched a public campaign urging California voters to support Proposition 38 [1]. The initiative, formally titled the Immunology Medical Research & Cures Initiative, proposes authorizing $8.4 billion in state funding dedicated to immunology research targeting conditions such as cancer, Alzheimer’s, heart disease, and diabetes [1][3]. This funding mechanism is designed to counteract recent federal funding cuts at the National Institutes of Health, which affected at least 160 active clinical trials nationwide in 2025 [1]. The proposition mandates a specific allocation model where 50% of funds are directed to competitive grants at California universities and nonprofits, while the remaining 50% support a University of California-affiliated nonprofit immunology institute [1]. To ensure fiscal responsibility, the measure includes a 2% cap on state administrative expenses and prohibits grant funding for for-profit corporations [1]. Additionally, the proposal requires that 10% of all immunotherapy licensing proceeds be returned to California to offset costs, and it mandates a 20% discount on immunotherapies developed for California patients compared to the national average [1].
Opposition and Alternative Funding Models
Conversely, progressive advocacy group Courage California announced its formal opposition to Proposition 38 on September 23, 2026, arguing the measure allows billionaires to misappropriate state funds for private research [2]. Instead of Prop 38, Courage California is advocating for Governor Newsom to sign SB 895, the California Science and Health Research Bond Act, by the September 30, 2026 deadline [2]. If passed by voters in March 2028, SB 895 would authorize $7.5 billion in bonds to establish the California Foundation for Science and Health Research and Innovation Acceleration Fund [2]. The League of Women Voters of California (LWVC) has also issued a recommendation to vote NO on Proposition 38, citing concerns over the borrowing structure which involves annual General Fund payments of approximately $500 million to $600 million for 20 years [4]. The LWVC opposes the measure alongside Propositions 37, 39, 41, 42, 43, 44, and 45, while supporting Propositions 1 through 5 [4].
Political Dynamics and Election Timeline
The political landscape surrounding the measure remains divided, with the California Democratic Party expressing pride in standing with over 60 organizations supporting Yes on Proposition 38 [5]. Party officials cite the Trump Administration’s cuts to medical research and scientists as a primary driver for the state-level intervention [5]. The campaign supporting the proposition is organized under the name “Californians for Life-Saving Immunology Research and Cures,” utilizing the tagline “Yes on 38” [3]. Voters will decide on Proposition 38 during the midterm election on November 3, 2026 [2]. Meanwhile, Courage California intends to mobilize its one million members to educate voters and campaign against the proposition through the election date [2]. If SB 895 is signed into law by the deadline, voters will face a subsequent decision on the alternative bond act in March 2028 [2].